The new heterocyclic compound 2-((6-chloro-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl) thiazole-5-carboxamide (1), designed using 2-chloro-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide (2) as start material, was successfully obtained via multistep synthesis route and finally characterized by IR (infrared radiation), 1H NMR (nuclear magnetic resonance), and single crystal X-ray crystallography. The inhibitory effect of compound 1 on human breast tumor cell line BS524 was further explored. The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and IC50 (half maximal inhibitory concentration) values suggested that compound 1 has significant anti-proliferation activity on BS524 cells and with low side effect. Then, serial experiments, such as the Annexin V-FITC/PI assay, TUNEL staining and autophagy detection revealed that compound 1 could inhibit cell proliferation via induce cells apoptosis, and the apoptosis is induced by (reactive oxygen species) ROS generation in BS524 cells.
UllahM.F., Breast Cancer: Current Perspectives on the Disease Status, Adv Exp Med Biol1152 (2019), 51–64.
2.
AnastasiadiZ., LianosG.D., IgnatiadouE., HarissisH.V., MitsisM., Breast cancer in young women: an overview, Updates Surg69 (2017), 313–317.
3.
OdleT.G., Precision Medicine in Breast Cancer, Radiol Technol88 (2017), 401M–421M.
4.
ElnairR., GalalA., Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib, BMC Cancer18 (2018), 1097.
5.
McKnightB.N., Viola-VillegasN.T., Monitoring Src status after dasatinib treatment in HER2+breast cancer with 89Zr-trastuzumab PET imaging, Breast Cancer Res20 (2018), 130.
6.
GiulianiS., SilvaA.C., BorbaJ.V.V.B., RamosP.I.P., PaveleyR.A., MuratovE.N., AndradeC.H., FurnhamN., Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents, PLoS Comput Biol14 (2018), e1006515.
7.
OchiengP., NathS., MacarulayR., EdenE., DaboA., CamposM., JiangX.C., ForonjyR.F., GeraghtyP., Phospholipid transfer protein and alpha-1 antitrypsin regulate Hck kinase activity during neutrophil degranulation, Sci Rep8 (2018), 15394.
8.
MologniL., Synergistic activity of dasatinib in combination with β-catenin blockade in colorectal cancer cells, Eur J Cancer104 (2018), 231–232.
9.
LuY., LiC.M., WangZ., RossC.R., ChenJ., DaltonJ.T., LiW., MillerD.D., Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure–Activity Relationships, J Med Chem52 (2009), 1701–1711.
10.
AbdellatifK., AbdelallE., AbdelgawadM., AhmedR., BakrR., Synthesis and Anticancer Activity of Some New Pyrazolo[3,4-d]pyrimidin-4-one Derivatives, Molecules19 (2014), 3297–3309.
11.
YinK., ChuD.K.,
DongX.R.,
WangC.,
DuanJ. A., and
HeJ., Femtosecond laser induced robust periodic nanoripples structured mesh for highly efficient oil-water separation, Nanoscale9 (2017), 14229–14235.
12.
WuK., DuK., HuG., Red-blood-cell-like (NH4)[Fe2(OH)(PO4)2]·2H2O particles: Fabrication and application in high-performance LiFePO4 cathode materials, J Mater Chem A6 (2018), 1057–1066.
13.
YangY., KangL., LiH., Enhancement of photocatalytic hydrogen production of BiFeO3 by Gd3+ doping, Ceram Int45 (2018), 8017–8022.
14.
WangK., PangJ., LiL., ZhouS., LiY., ZhangT., Synthesis of hydrophobic carbon nanotubes/reduced graphene oxide composite films by flash light irradiation, Front Chem Sci Eng12 (2018), 376–382.
15.
WangJ.Y., WangX., WangX.J., ZhengB.Z., WangY., WangX., LiangB., Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells, Eur Rev Med Pharmacol Sci22 (2018), 7492–7499.
